This podcast explores the groundbreaking CORA system developed by the medical technology start-up AccuLine, which aims to revolutionize the early detection of coronary artery disease (CAD). Designed for primary care settings, the CORA system is a non-invasive, point-of-care diagnostic tool that uses artificial intelligence to analyze a patient's electrical cardiac activity, blood oxygen levels, and respiratory rate during a simple four-minute resting exam. The discussion highlights the severe limitations and inaccuracies of traditional stress tests, contrasting them with CORA's impressive recent clinical trial results in Israel, where the technology achieved a 94% sensitivity and a 99% negative predictive value in ruling out CAD against the gold standard of invasive angiography. Finally, the episode touches upon AccuLine's strategic collaboration with the Mayo Clinic and its upcoming 2,000-patient U.S. clinical trial, which will pave the way for anticipated FDA clearance and future commercial availability in the United States.

In this episode of the Deep Dive, we unpack Matt Shumer’s Fortune article, "Something big is happening in AI — and most people will be blindsided," exploring the silent but seismic shift from passive chatbots to autonomous "agentic AI" that is rapidly rendering traditional white-collar workflows obsolete. The discussion illuminates the dangerous "perception gap" between the public’s view of AI as a toy (the "flip phone" era) and the reality of powerful, self-correcting agents that act as tireless employees, arguing that we have moved past the "hallucination phase" into an era where AI can execute complex projects with minimal human intervention. We break down Shumer’s urgent playbook for survival, detailing why paying for top-tier models is a career imperative, how to adopt the "one hour a day" experimentation habit, and why transforming into a "builder" who directs these tools is the only way to stay above the rising water of automation.

This is a NotebookLM audio overview of the material covered in Chapter 1 of the linguistics textbook, "Essentials of Linguistics."

NotebookLM podcast hosts discussing Chapter 1 of “Psychology in Your Life.”

NotebookLM hosts discussing a YouTube video which explains how to use Claude Code and Google Antigravity together to make your workflow much more efficient.

This podcast episode provides a comprehensive look at the history, evolution, and recent cinematic debut of Marvel’s Wonder Man, Simon Williams. The hosts explore his 1964 comic book origins as a failed industrialist and accidental villain through to his complex, modern-day depiction in the 2026 Disney+ series. Listeners will hear an insightful breakdown of the character’s most pivotal moments, including his connection to Vision, his stint as a "zombie" hero, and his transition into a celebrity actor in Los Angeles. The discussion also highlights significant changes in the character's MCU origin story, such as his potential status as a mutant and the introduction of the restrictive "Dorman Clause" labor law. Whether you are a long-time fan of the West Coast Avengers or a newcomer intrigued by the new series, this episode offers a detailed look at one of Marvel’s most human and paradoxical heroes.

This is a deep dive podcast covering Chapter 1 of “Psychology in Your Life.“

Breakthrough in Pancreatic Cancer Research

Pancreatic cancer has a five-year survival rate of 13% as of January 2026. This episode discusses a new triple therapy study published in the Proceedings of the National Academy of Sciences. Dr. Mariano Barbacid and researchers at the Spanish National Cancer Research Centre (CNIO) developed a treatment that eradicated pancreatic tumors in mice. The tumors did not return for more than 200 days after the mice stopped receiving the medication.

The treatment targets three specific pathways simultaneously: KRAS, EGFR, and STAT3. It uses a combination of three drugs. Duraxonrasib is a KRAS-on inhibitor currently in Phase 3 human trials. Afatinib is an FDA-approved drug already used to treat lung cancer. SD-36 is an experimental molecule that forces the body to clear broken cancer cells.

You should care about this episode because it describes a shift toward a potential cure instead of standard disease management. The podcast explains why previous single-drug treatments failed and how this new engineering approach prevents cancer from building resistance. You will learn about the science behind these results and the expected timeline for human availability.

Claude Cowork is an advanced agentic AI application designed to function as a "personal AI employee" for non-technical users, capable of accessing local files, controlling web browsers, and integrating with external tools to execute complex workflows rather than just answering questions. It can be used for a wide variety of administrative and creative tasks, such as autonomously organizing desktop files, creating branded slide presentations, analyzing data trends from spreadsheets, managing emails and calendar schedules, and performing browser-based actions like filling out forms or scraping web data. The general public finds it useful because it democratizes powerful automation, allowing individuals without coding skills to offload repetitive, time-consuming drudgery to an always-available assistant that actively performs work on their computer, ultimately freeing up time for more creative endeavors.